Litcius/Paper detail

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC

Sally C. M. Lau, Madhumitha Rabindranath, Jessica Weiss, Janice J.N. Li, Andrea S. Fung, Dorinda Mullen, Najd Alshamlan, Heather Ruff, Leung Chu Tong, Prodipto Pal, Michael Cabanero, Ying-Han R. Hsu, Adrian G. Sacher, Frances A. Shepherd, Geoffrey Liu, Penelope A. Bradbury, Kazuhiro Yasufuku, Katarzyna Czarnecka‐Kujawa, Hyang Mi Ko, Ming‐Sound Tsao, Natasha B. Leighl, Joerg Schwock

2022Lung Cancer12 citationsDOI

Topics & Concepts

CytologyMedicineHistologyInternal medicineLung cancerPD-L1BiomarkerOncologyCancerPathologyGastroenterologyImmunotherapyBiologyBiochemistryCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC | Litcius